|
Awards/Accolades
Bluegrass Business Development Partnership, a one-stop service provider, wins international economic development award for partnership formed with UK, Lexington city government and Commerce Lexington
Center for Rural Development in Kentucky's 5th Congressional District names Joe Fink, a UK professor of pharmacy law and policy, as chair
College of Pharmacy ranks No. 5 in the nation according to U.S. News and World Report; new 280,000-sq. ft. pharmacy building will be among the largest in the country
Delta Sky magazine, with an estimated 3.4 million readers, features a 60-page special section on Lexington's Bluegrass Region, including the University of Kentucky and Coldstream Research Campus
Lexington ties for 10th best metro area for new industry location and expansion projects according to Site Selection magazine; Kentucky also ranks No. 10 in state rankings and No. 12 for the most new corporate facilities and expansions
U.S. Small Business Administration presents leadership award to Kentucky State Director Becky Naugle
Business Development
$4.3 million to 12 UK affiliated companies from Kentucky's SBIR/STTR Matching Program; companies successfully competed for $5.9 million in federal SBIR/STTR awards
135 licenses with business and industry for UK intellectual properties/technologies
13 new UK companies: Advanced Machine Technologies Scott Stephens, engineering / Alkymos Bob Yokel, pharmacy / Cherry Orchard Products Mike Jay, formerly pharmacy / CoPlex Therapeutics Mark Lovell & Bert Lynn, chemistry / Fresh Flavors and Fragrances David Hildebrand, agriculture / IP Pharmaceuticals Guangxiang Luo, medicine / MCC Technologies Tom Robl & Jack Groppo, Center for Applied Energy Research / Metal Separation Technologies Eric Grulke, engineering / Michael Troy Larry Hassebrook, engineering / NanoTech Solutions Vijay Singh, engineering / Neathery Technologies Jim Neathery, Center for Applied Energy Research / TranSecurity Systems Fred Payne, agriculture / Viro Tac Guangxiang Luo, medicine
"Bench2Business" networking events, hosted by UK President Lee Todd, bring more than 100 faculty together with potential investors, business service providers and community leaders; includes faculty presentations on emerging technologies
BIO International Convention, attended by 20,000 industry leaders from 70 countries and 48 states, partners UK and Commerce Lexington to promote biotech research, facilities and Coldstream Research Campus; Naprogenix, Scout Diagnostics, Transposagen Biopharmaceuticals and Coldstream Laboratories Inc. also attended
Dean Harvey is named UK's new Executive Director for Business Development/Von Allmen Center for Entrepreneurship; Pat Powell joins UK as Director of the Lexington Innovation & Commercialization Center
Kentucky Small Business Development Center (KSBDC) inducts 12 state-wide businesses into the inaugural class of the Pacesetter Business Program for high-performing, second-stage companies that are changing Kentucky's economic landscape
KSBDC impacts business development statewide; 387 long-term clients served, 145% increase; 129 new businesses; 784 jobs created; $40.7 million capital infusion
Therix Medical, a creative new business development model, is developed for UK clinicians to bring innovations to market
Capital Investments
$64.5 million in venture funding secured by Lexington/Bluegrass Region early-stage companies according to the Lexington Venture Club annual survey; nearly 60% of companies are affiliated with UK
$6.5 million secured for redundant electrical power and fiber optics at UK's Coldstream Research Campus
$3.6 million invested to date in 14 tech-based companies by the Bluegrass Angels and Bluegrass Angels Venture Fund (public/private partnership with angels, UK and Commonwealth Seed Fund); four investments based on UK research and one on UofL research; most deals syndicated
Allylix licenses its technology to a leading biofuels company which will develop terpene fuels and fuel additives; receives $3.35 million to launch first three products (located at UK's Coldstream Research Campus)
Cleveland Clinic's Tolera Therapeutics licenses a monoclonal antibody to facilitate the immune system's tolerance to grafts and transplantation; developed by John Thompson, MD, former UK chair of Internal Medicine
CoPlex Therapeutics closes the first round of investment; R&D to provide neuroprotection from dementia caused by unique protein complex discovered at UK (located at UK's ASTeCC incubator)
Investors network formed by Commercialization & Economic Development office; includes five regional angel investor groups and seven venture capital groups
Kentucky Technology Inc., UK's for-profit technology investment corporation, develops new business model for licensing and real estate investment opportunities
LevTech, a leading provider of disposable mixing technologies to the biotechnology and pharmaceutical industries, acquired by ATMI Inc. for $27 million (located at UK's Coldstream Research Campus)
Mersive Technologies, producer of ultra high resolution and flexible digital displays, completes $4.6 million Series B financing round led by Hopewell Ventures from Chicago; announces agreement with Antycip Simulation Ltd. to distribute Mersive's products in Europe
RhinoCyte, developing diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases, receives FDA "orphan drug" approval for drug to treat ALS, commonly known as Lou Gehrig's Disease
Coldstream Research Campus
11 new companies: Alloy Technology Innovations, Advanced Dynamics, Berryceuticals, BP Barber, Fisher Scientific, HP, Kentucky Horse Council, Lawrence Pharmaceuticals, Nanoconcepts, Proctive Consulting, Topasol (UK's ASTeCC incubator "graduate")
Advanced Dynamics, specializing in integrated and high-fidelity aerodynamics modeling and simulation, receives multiple SBIR/STTR awards from NASA, Air Force Office of Scientific Research and the Army; works on release of large scale software tool sets |
Coldstream Laboratories Inc., a $17 million state-of-the-art contract manufacturing facility for small-batch sterile drug products, completes first successful year of operation with 26 national/international pharmaceutical and biotech clients
Exstream Software, a 10-year old Lexington company providing enterprise document automation solutions co-founded by UK alumnus Davis Marksbury, opens world headquarters with 144 Lexington-based employees; Hewlett-Packard Co. acquires Exstream Software
Laura's Lean Beef was sold to Meyer Natural Angus; offers naturally-lean beef products from cattle raised on a vegetarian diet without growth hormones or antibiotics
Lexhold Center for Technological Innovation signs leases with eight businesses as construction continues on the first building of the $50 million facility
Livestock Disease Diagnostic Center will undergo a $28.5 million renovation and expansion; UK College of Agriculture holds groundbreaking ceremony
Master development plan update begins, including sustainable architecture and mixed land use guidelines; hires international planning, environmental and design firm EDAW Inc. and ERA, a market analysis/strategy development firm
Public Safety Operations Center building design begins; will serve Lexington-Fayette County and surrounding counties
Redundant electrical power and fiber optics will be available in first quarter 2010; second substation under construction
State mental health facility will relocate to Coldstream; planning underway; construction expected to begin in 2010
Incubator Companies
AllTranz continues product development / proof-of-concept testing of lead product formulation for osteoarthritis with $1.26 million in Series A financing; prepares for pre-IND FDA meeting
Adaptive Intelligent Systems receives $470,000 for two Phase I and a Phase II SBIR research projects to improve welding technology and welding systems
Coldstream Digital completes plan with KY Transportation Center for Oak Ridge National Laboratory hazardous materials truck tracking center; receives $3.5 million contract from the National Institute for Hometown Security to build center prototype
Emagin Therapeutics continues R&D on two products to treat acute, chronic and cancer related pain; developing new delivery systems for pain medication
IP Pharmaceuticals has two new licenses with UK; develops therapeutics and vaccines to treat infectious diseases such as hepatitis, influenza, Dengue, and West Nile Virus
Nano-Mite Technologies, working on combating obesity by increasing metabolism, continues clinical R&D in lab animals and concludes three successful trials including toxicity assessment; management team put in place
Naprogenix completes three NIH STTR Phase I breast cancer and alcoholism research projects; receives $618,000 for a Phase II NIH STTR for alcoholism treatment
NeoCytex Biopharma receives NIH funding to develop therapeutics to repair tissues damaged by neurodegenerative diseases
Outrider Technologies continues work on next generation semiconductor materials; Sony uses TIPS molecule to make 10" display; becomes gold standard for the plastic electronic industry
Oraceuticals, using natural products to prevent oral diseases, completes STTR Phase I research; prepares anti-caries chewing gum for clinical evaluation
ParaTechs licenses VE-BEVS technology to a pharma company that is developing therapy treatments for cancer; launches NSE™, a patented device that enables non-surgical embryo transfer in rodents to produce transgenic mice; receives USDA Phase II SBIR to continue R&D on agricultural pest control alternatives
Scout Diagnostics elected to the Foundation for NIH Biomarkers Consortium; diagnostic biomarker research published in Neurology
Synergetic Technologies developing new particle characterization technology; work funded by NSF SBIR
Transposagen Biopharmaceuticals, producer of unique animal models of human diseases for drug research, relocates from Philadelphia, Pa. to Lexington to take advantage of Kentucky's SBIR/STTR Matching Program
Tribo Flow Separations receives NSF SBIR Phase I for R&D on a technique and sensors to detect in real time the metabolic activity of microbes and cells and their susceptibility to either drug treatments or viral infections
Yaupon Therapeutics developing four products to treat cancer and central nervous system diseases; includes a compound to treat ADHD in Phase I clinical trials
Industry Partnerships
$20.4 million in industry grants & contracts
Alltech receives $30 million from the Department of Energy to establish a biorefinery for cellulose ethanol in Springfield, Ky.; will employ 93 people when operating at full capacity in 2010; expands R&D partnership with the University of Kentucky's Center for Applied Energy Research
Center for Applied Energy Research receives a $1.2 million international grant to explore energy-storage technologies; $1.4 million from DoE for ongoing research to refine coal into liquid transportation fuels
Len Heller introduces UK to Fortune 500 companies through the National Academies University-Industry Demonstration Partnership; works on IP issues with the NASULGC Commission on Innovation, Competitiveness and Economic Prospertiy
Procter & Gamble signs a master research agreement with UK to develop sustainable and environmentally friendly phytochemicals; UK team leaders are plant and soil sciences researchers George Wagner, Joe Chappell, Guiliang Tang and Ling Yuan
Public Partnerships
Automated guideway mass transit exploratory study begins; UK partners with city and state officials and community leaders on project
Partnership for Growing Local Economies formed by UK's Appalachian Center, Cooperative Extension, Kentucky Entrepreneurial Coaches Institute, and the Kentucky Small Business Development Center; meets with Eastern Kentucky local, regional and state ED representatives |
